|
summary: This multi-centre randomised placebo-controlled trial showed that treating people with clinically isolated syndromes with interferon delays the onset of MS at two years. Ongoing work is looking at whether this effect is sustained at five years.
authors: Kappos L, Polman CH, Freedman MS, Edan G, Hartung HP, Miller DH, Montalban X, Barkhof F, Bauer L, Jakobs P, Pohl C, Sandbrink R.
source: Neurology. 2006 Oct 10;67(7):1242-9. Epub 2006 Aug 16.
weblink: click here
category: Clinical Trials and Therapeutics
related research news: click here
glossary:
ACE
Interferon
Placebo
Randomised
|
